BALDINI, EVA
 Distribuzione geografica
Continente #
EU - Europa 903
NA - Nord America 695
AS - Asia 120
AF - Africa 3
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
SA - Sud America 1
Totale 1.726
Nazione #
US - Stati Uniti d'America 693
GB - Regno Unito 452
IE - Irlanda 138
CN - Cina 92
UA - Ucraina 68
FR - Francia 62
IT - Italia 62
SE - Svezia 58
FI - Finlandia 22
BE - Belgio 13
ES - Italia 12
TR - Turchia 12
DE - Germania 11
IN - India 10
PL - Polonia 5
VN - Vietnam 4
CA - Canada 2
EU - Europa 2
AU - Australia 1
EG - Egitto 1
LK - Sri Lanka 1
NZ - Nuova Zelanda 1
PE - Perù 1
SL - Sierra Leone 1
TW - Taiwan 1
ZA - Sudafrica 1
Totale 1.726
Città #
Southend 410
Dublin 137
Chandler 102
Fairfield 84
Ann Arbor 69
Ashburn 65
Jacksonville 63
Wilmington 45
Seattle 34
Woodbridge 33
Beijing 32
Cambridge 28
Houston 27
Lancaster 25
Princeton 18
Nanjing 17
Brussels 13
Helsinki 13
Menlo Park 13
Siena 13
Boardman 12
Málaga 12
Izmir 11
Dearborn 10
Pune 9
Milan 8
Nanchang 8
New York 8
Shenyang 6
Tianjin 5
Dong Ket 4
San Diego 4
Changsha 3
Düsseldorf 3
Haikou 3
Jinan 3
Redwood City 3
San Mateo 3
Jiaxing 2
Ningbo 2
Rome 2
San Francisco 2
Venezia 2
Wandsworth 2
Auckland 1
Baotou 1
Berlin 1
Brisbane 1
Cairo 1
Centurion 1
Changchun 1
Colombo 1
Falkenstein 1
Freetown 1
Fremont 1
Fuzhou 1
Hangzhou 1
Hebei 1
Hefei 1
Kunming 1
Latina 1
London 1
Los Angeles 1
Markham 1
Norwalk 1
Prato 1
Shanghai 1
Shaoxing 1
Stefania 1
Taipei 1
Torino 1
Toronto 1
Towson 1
Wenzhou 1
Zhengzhou 1
Totale 1.399
Nome #
Inhibiting PNP for the therapy of hyperuricemia in Lesch-Nyhan disease: preliminary in vitro studies with analogues of immucillin-G 239
Up-regulation of NADPH oxidase-mediated redox signaling contributes to the loss of barrier function in KRIT1 deficient endothelium 201
Use of the yeast two-hybrid technology to isolate molecular interactions of Ras GTPases 194
Ras GTPases are both regulators and effectors of redox agents 190
NUOVA TERAPIA PER IL TRATTAMENTO DELL'IPERURICEMIA NELLA SINDROME DI LESCH-NYHAN 141
null 137
Cerebral Cavernous Malformations: from disease mechanisms to novel therapeutic approaches 109
Oxidative stress and Cerebral Cavernous Malformations (CCM): from disease mechanisms toward prevention and treatment 97
Cerebral Cavernous Malformations: the CCM Italia research network offers new therapeutic perspectives 94
null 93
Metabolic engineering of Saccharomyces cerevisiae for the production of plant derived antioxidants 90
null 71
Evaluation of the bioactive properties of avenanthramide analogs produced in recombinant yeast. 45
Metabolic engineering of yeast for the production of plant avenanthramide analogous endowed with antioxidant and antiproliferative properties 42
Metabolic engineering of Saccharomyces cerevisiae for the production of avenanthramide analogous endowed with bioactive properties 19
Totale 1.762
Categoria #
all - tutte 4.160
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.160


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019124 0 0 0 0 0 0 0 0 0 0 59 65
2019/2020409 69 15 24 48 45 28 21 49 32 36 24 18
2020/2021310 14 21 0 50 44 25 16 36 24 49 13 18
2021/2022185 17 26 6 22 9 4 5 17 12 20 14 33
2022/2023268 12 23 33 39 41 49 4 24 15 14 6 8
2023/2024204 6 3 9 16 9 64 80 14 1 2 0 0
Totale 1.762